- conhecimento Artigos &publicações Overall Survival and Economic Impact of Triple-Negative Breast Cancer in Brazilian Public Health Care: A Real-World StudyOncoplastic surgery in the treatment of breast cancer: a review of evolution and surgical trainingOncological outcomes of breastconserving surgery versus mastectomy following neoadjuvant chemotherapy in a contemporary multicenter cohortNational Survey on Attitudes of Brazilian Breast Surgeons Regarding Oncoplastic Surgery: Success of a Training ModelIs axillary surgery still justified in DCIS diagnosed via vacuum-assisted biopsy?Immunohistochemical Changes After Neoadjuvant Chemotherapy and Their Impact on Breast Cancer Survival: A Systematic Review and Meta-analysisHypofractionated whole and partial breast irradiation: Brazilian Society of Radiotherapy (SBRT) consensusMammographic screening: hero or villainFirst-line lenvatinib plus pembrolizumab versus chemotherapy for advanced endometrial cancer: 1-Year follow-up after final analysis of the ENGOT-en9/LEAP-001 phase 3 trialDisparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil’s public and private healthcare systems « Entradas Mais Antigas Próximas Entradas »
Overall Survival and Economic Impact of Triple-Negative Breast Cancer in Brazilian Public Health Care: A Real-World Study
Oncological outcomes of breastconserving surgery versus mastectomy following neoadjuvant chemotherapy in a contemporary multicenter cohort
National Survey on Attitudes of Brazilian Breast Surgeons Regarding Oncoplastic Surgery: Success of a Training Model
Immunohistochemical Changes After Neoadjuvant Chemotherapy and Their Impact on Breast Cancer Survival: A Systematic Review and Meta-analysis
Hypofractionated whole and partial breast irradiation: Brazilian Society of Radiotherapy (SBRT) consensus
First-line lenvatinib plus pembrolizumab versus chemotherapy for advanced endometrial cancer: 1-Year follow-up after final analysis of the ENGOT-en9/LEAP-001 phase 3 trial
Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil’s public and private healthcare systems
